XML 40 R29.htm IDEA: XBRL DOCUMENT v3.5.0.2
Equity (Tables)
9 Months Ended
Sep. 30, 2016
Equity [Abstract]  
Shareholders' Equity
 
  
Common Stock
Other
Paid-In
Capital
Retained
Earnings
Accumulated
Other
Comprehensive
Loss
 
Treasury Stock
Non-
Controlling
Interests
Total
($ and shares in millions)
Shares
Par Value
Shares
Cost
Balance at January 1, 2015
3,577

$
1,788

$
40,423

$
46,021

$
(4,323
)
739

$
(35,262
)
$
144

$
48,791

Net income attributable to Merck & Co., Inc.



3,465





3,465

Other comprehensive loss, net of tax




(250
)



(250
)
Cash dividends declared on common stock



(3,826
)




(3,826
)
Treasury stock shares purchased





53

(3,005
)

(3,005
)
Share-based compensation plans and other


(263
)


(17
)
840


577

Changes in noncontrolling ownership interests


(21
)




(55
)
(76
)
Net income attributable to noncontrolling interests







12

12

Distributions attributable to noncontrolling interests







(9
)
(9
)
Balance at September 30, 2015
3,577

$
1,788

$
40,139

$
45,660

$
(4,573
)
775

$
(37,427
)
$
92

$
45,679

Balance at January 1, 2016
3,577

$
1,788

$
40,222

$
45,348

$
(4,148
)
796

$
(38,534
)
$
91

$
44,767

Net income attributable to Merck & Co., Inc.



4,515





4,515

Other comprehensive loss, net of tax




(104
)



(104
)
Cash dividends declared on common stock



(3,835
)




(3,835
)
Treasury stock shares purchased





44

(2,418
)

(2,418
)
Share-based compensation plans and other


(325
)


(25
)
1,235


910

Changes in noncontrolling ownership interests







124

124

Net income attributable to noncontrolling interests







13

13

Distributions attributable to noncontrolling interests







(15
)
(15
)
Balance at September 30, 2016
3,577

$
1,788

$
39,897

$
46,028

$
(4,252
)
815

$
(39,717
)
$
213

$
43,957